Universal logo

About Us

What we do

We provide chemistry services and are capable of supplying products from gram to multi kilo scale involving complex and multi-step synthesis. We supply to biotech and pharma customers to accelerate early-stage drug discovery and pre-clinical to clinical research programs. We also supply advanced intermediates and API’s going for toxic studies enabling IND filing.

We conduct process R&D, technology transfer and manufacture of key starting materials, advanced intermediates for APIs going to clinical studies. We have partnered with WHO GMP and ISO 9001-2008 facilities located in India.

In addition, we develop novel synthetic methodologies and synthesize deuterium labelled drug standards, intermediates and metabolites and supply to leading pharmaceutical companies all over the world. We also develop and manufacture Semio chemicals for crop protection including specialty chemicals for photography applications.

Custom Synthesis

We offer custom synthesis and manufacturing services for biotechnology, pharmaceuticals, life science and chemical research related industries. We can also exercise an existing synthesis or design a new synthesis when there is no developed chemical route of synthesis.

Process Research

We can undertake projects for process research, scale up and technology commercialization for pharmaceutical intermediates, APIs for preclinical and clinical drug candidates.

We also conduct process R&D and develop technology for manufacture of deuterated intermediates and APIs for clinical studies and commercial launch.

Drug-like and Lead-like Compounds for Screening

  • We provide a diverse library of small molecule compounds for screening against your targets
  • We can create a synthesis plan for your hit compounds
  • We can design and synthesize a custom library for lead identification and lead optimization

Why SVChemBiotech?

Our experience, combined with state-of- the-art laboratories and manufacturing facilities lets us become an ideal partner for the pharmaceutical and drug discovery industry. We work efficiently and offer a competitive price while maintaining full confidentiality regarding clients' intellectual property.

Drug development today is more challenging. Success requires precision, adaptability, and a partner who can deliver complex chemical synthesis with speed and quality. For pharmaceutical manufacturing companies and innovators in the biotech sector, finding a suitable collaborator is essential. Whether it is creating custom molecules, scaling a process for clinical trials, or supporting regulatory demands, companies need a team that is proactive, scientifically rigorous, and fully aligned with their goals. We bring this partnership approach to every project, helping clients to accelerate discovery while managing risk and costs. At SV ChemBioTech, we are proud to serve as the trusted partner.

What We Do: Comprehensive Chemistry Services Built for Your Success

We provide a broad range of chemistry services tailored to support pharmaceutical manufacturing companies and biotech companies across the globe. Our work spans everything from the delivery of gram-scale novel compounds to the large-scale production of advanced pharmaceutical intermediates and APIs designed for toxicology and clinical research. Clients rely on us to transform their early-stage ideas and complex synthetic challenges into consistent, high-quality products that meet stringent regulatory standards.

Our capabilities include:

  • Custom synthesis of novel organic molecules, including multi-step and complex synthesis
  • Process research and development to optimize routes and enable smooth technology transfer to manufacturing
  • Large-scale production with GMP-compliant partners to support clinical supply
  • Development and supply of specialized compounds such as deuterium-labelled drug standards, metabolites, and impurities
  • Production of small molecule libraries and advanced intermediates that support efficient drug screening and development
  • Specialty chemicals including semio chemicals for agriculture and unique products for imaging applications

Why Choose Us: Aligning with Your Business Objectives

Our goal is not only to provide molecules but to become an extension of your R&D team. We recognize that timelines, confidentiality, and regulatory requirements can make or break project outcomes, so we emphasize:

  • Close collaboration and open communication to stay ahead of challenges and adjust as projects evolve
  • Rigorous quality and analytical controls ensuring batch-to-batch consistency and regulatory compliance
  • Flexibility across small-scale discovery runs and kilo-scale manufacturing to align with client milestones and budgets
  • Deep technical expertise from a leadership team rooted in both scientific innovation and industry experience

Our approach ensures you retain control and confidence, knowing your complex chemistry needs are handled by dedicated professionals.

What Sets SV ChemBioTech Apart?

  • Experienced PhD-led scientific team with decades of drug discovery, medicinal chemistry, and process development experience
  • Canadian-based operation connected globally with WHO GMP and ISO-certified manufacturing facilities, guaranteeing both quality and scalability
  • Proven track record supporting clients in oncology, CNS, infectious diseases, metabolic disorders, and rare diseases
  • Ability to offer full-service custom organic synthesis services in Canada, combining innovation with cost-effective methodologies
  • Commitment to maintaining strict confidentiality, protecting your intellectual property and competitive advantage

How We Support Life Sciences Industry Ecosystem

As a recognized pharma CRO company, and a leading contributor within the Canadian life sciences landscape, we are proud to partner with companies of all sizes—from emerging startups to established pharmaceutical giants. Our location and expertise connect Alberta’s biotech community to international markets and advanced manufacturing, providing a strategic advantage for local innovation that is globally competitive. We understand that every project is unique, whether it involves developing new chemical entities, optimizing processes, or supplying critical reference standards. We tailor our services with precision and flexibility to empower your success effectively.

FAQs

  1. What services do you provide to pharmaceutical manufacturing companies?

    We offer custom synthesis, process R&D, scale-up, GMP manufacturing support, and analytical services.

  2. Why is SV ChemBioTech a leading biotech company in Edmonton?

    Our experienced scientific team, commitment to quality, and local presence position us as a trusted innovation partner.

  3. How do biotech companies benefit from working with you?

    They gain access to tailored chemistry solutions, regulatory support, and scalable manufacturing with clear communication.

  4. What makes you a preferred pharma CRO company?

    Our flexible engagement, confidentiality, and end-to-end drug discovery support align with client needs and timelines.

Contact Us

We invite you to explore how SV ChemBioTech can support your next research or development project. For inquiries or quotes, please contact us.

SVChemBiotech Conference Gallery

News

  • 2026

    SV ChemBioTech was awarded a prestigious Canadian federal procurement contract (Ref: W7702-266459, “Synthesis of Molecules of Interest”) by Defence Research and Development Canada and Public Services and Procurement Canada. Valued at CA$525,000, the contract supports custom chemical synthesis of targeted compounds for defense and security research applications.

    We also joined the Mitacs Business Strategy Internship program in partnership with Advanced Pharmaceutical Innovation and the University of Alberta, hiring its first Mitacs-BSI intern in May 2026. The program supports collaboration among students, postdoctoral fellows, industry partners, and academic researchers to address business challenges, drive innovation, improve operations, and develop new opportunities.

  • 2025

    We hired two R&D Trainees in partnership with Technology Alberta through the First Jobs Tech BOOST program-200 hrs. The trainees are engaged in ongoing research focussed on developing a novel deuteration technology.

    We hosted Ritu Banerjee - Assistant Deputy Minister, Office of Life Sciences and Biomanufacturing Readiness at ISED Canada. ISED works with Canadians in all parts of the country to improve conditions for investment, enhance Canada's innovation performance and increase Canada's share of global trade, and build a fair, efficient and competitive marketplace.

  • 2024

    We developed a novel synthetic route and supplied an anti-cancer drug candidate to a Canadian customer, Lab and Farm Capital, to support their research project aimed at toxicology studies.

    We designed a novel route of synthesis and supplied a drug candidate for anti-inflammatory studies to Edmonton based -small biotech company. This project was funded by EDMONTON UNLIMITED.

    The SV ChemBioTech executive team attended CPHI WORLDWIDE 2024 held in Milan, Italy

  • 2023

    In November 2023, we hired two R&D Trainees (pharmaceutical R&D and manufacturing) in SV ChembioTech in partnership with Technology Alberta through the 'First Jobs, Work Integrated Learning (WIL)' program.

    FIRST Jobs (First Industrial Research, Science, or Technology) is a Job placement partnership program between Alberta companies and Technology Alberta, with support from the Government of Alberta and the Government of Canada.

  • 2021

    Developed efficient, cost-effective syntheses and scale up of lead drug candidates and delivered to large pharma customer, AstraZeneca, EMD Serono, USA.

    Developed an efficient scale up synthesis of L-2-Aminooxy-3-Phenylpropionic Acid and delivered to our customer University of Florida.

    Developed an efficient scale up synthesis of a chiral auxiliary compound and delivered to large pharma customer, Eli Lilly, USA.

    SV Chem received "MITACS Accelerate Industrial Joint Postdoc" to support research, technology commercialization of complex pheromone products for supplying to a prestigious customer in California. For this project, we have signed a research collaboration with a chemistry professor from University of Alberta, Edmonton.

  • 2020

    We received Industry R&D Associates Program Grant from Alberta Innovates, Canada to develop advanced chlorination technology for optimizing existing manufacturing process for one of our commercial products, CRS pheromone.

  • 2019

    Awarded with NRC Industrial Research Assistance Program (NRC-IRAP), by National Research Council Canada for developing an efficient, cost-effective “Oxidation technology” to use in the manufacturing of an API intermediate. The API is used for treating Parkinson’s disease, hyperprolactinemic disorders.

    Awarded with NSERC Engage / Alberta Innovates CASBE Grant to conduct research on "High-throughput microfluidic technology" for developing small 3D tissues to identify new therapeutic pathways for cancer therapy in collaboration with University of Calgary.

  • 2018

    Developed novel synthesis and delivered complex library compounds to EMD Serono.

    Developed synthesis of a complex chiral beta-amino acid, delivered to Merck KGaA.

    Developed and delivered complex med-chem screening compounds to Biogen.

    Developed and delivered novel synthetic routes for various deuterium drug standards and metabolites to clients.

    Developed a novel route for synthesis of a green house pheromone(SMID: ascr#18, active on organism C. elegans) and delivered to a customer in California, USA for field trials.

    Participated in CPhi Worldwide 2018 held in Madrid, attended an introductory session organized by the Canadian Ambassador to Spain

    Our President has been invited to speak in the 102nd Canadian Chemistry Conference and Exhibition in June 2019 in Quebec, Canada, organized by the Canadian Society for Chemistry.

  • 2017

    Participated in Bio International Convention 2017 held in San Diego, USA.

    Developed an efficient synthesis for a key intermediate of a preclinical API and delivered to a customer in USA. We received appreciation from the customer for successful execution of synthesis and timely delivery. Customer placed with us another order for a 2 nd campaign of the same intermediate.

    Developed a manufacturing process and delivered in multiple kilos of California red scale Pheromone (CRS pheromone) to a customer in Canada. CRS pheromone is used for control of California red scale pest on citrus trees.

  • 2016

    Received NSERC Engage Plus award from NSERC Canada to conduct research on “Efficient Chemical Synthesis of Deuterated Pharmaceutical Standards and Metabolites” in collaboration with University of Alberta.

    Initiated and completed a multi-kilo project for a US customer for developing and manufacturing of an advanced intermediate for a clinical API used in treating HIV infection and AIDS.

  • 2015

    Participated in a collaborative research project "Copper-Mediated Carbon-Carbon Bond Formation Reactions with Heterocyclic Compounds" with University of Alberta supported by “NSERC Engage” from Natural Sciences and Engineering Research Council of Canada.

  • 2014

    Developed a novel manufacturing process of an advanced intermediate for a clinical API used in treating Friedreich’s ataxia. Supplied multi kilos quantities to a customer in USA.

    Developed a multi-step novel synthesis for an advanced intermediate of a generic API used for treating Parkinson's disease. Supplied in kilo quantities to a customer in Brazil.

  • 2013-2016

    Developed novel synthetic routes and delivered several complex “New Chemical Entities” to Thermofisher Scientific's customer Sanofi for drug discovery programs.

  • 2012-2013

    Entered into a collaboration with Indian manufacturing facility for research and developing a new technology for an advanced intermediate for a pre-clinical drug used in treating “Friedreich’s ataxia”, rare inherited disease that causes nervous system damage.

  • 2011-2012

    Participated in a collaboration with Albany Molecular Research (USA) to develop and deliver various complex “New Chemical Entities” for pre-clinical research. Received an appreciation from the customer.